Zobrazeno 1 - 10
of 236
pro vyhledávání: '"FRÉDÉRIC HOUSSIAU"'
Autor:
Paraskevi Chairta, Paschalis Nicolaou, Kleitos Sokratous, Christine Galant, Frédéric Houssiau, Anastasis Oulas, George M. Spyrou, Marta E. Alarcon-Riquelme, Bernard R. Lauwerys, Kyproula Christodoulou
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-9 (2020)
Abstract Background Pathogenesis and aetiology of systemic sclerosis (SSc) are currently unclear, thus rendering disease prognosis, diagnosis and treatment challenging. The aim of this study was to use paired skin biopsy samples from affected and una
Externí odkaz:
https://doaj.org/article/776684f593b243b6ae395cd485ba3138
Autor:
Thomas Kirchgesner, Xavier Demondion, Maria Stoenoiu, Patrick Durez, Adrien Nzeusseu Toukap, Frédéric Houssiau, Christine Galant, Souad Acid, Frédéric Lecouvet, Jacques Malghem, Bruno Vande Berg
Publikováno v:
Insights into Imaging, Vol 9, Iss 5, Pp 761-771 (2018)
Abstract The fascial system is a three-dimensional continuum of connective tissues present everywhere throughout the body, from the head to the toes and from the skin to the bone. The current article aims to review the normal anatomy of the fasciae o
Externí odkaz:
https://doaj.org/article/ae66c57176dd4c84b1c8dc541329ab1d
Autor:
Richard Furie, Brad H. Rovin, Frédéric Houssiau, Gabriel Contreras, Y.K. Onno Teng, Paula Curtis, Yulia Green, Mohamed Okily, Anuradha Madan, David A. Roth
Publikováno v:
Clinical Journal of the American Society of Nephrology, 17(11), 1620-1630. AMER SOC NEPHROLOGY
Background and objectives In the BLISS-LN study, belimumab improved kidney outcomes in adult patients with active lupus nephritis. This 28-week open-label extension of BLISS-LN assessed belimumab's safety and efficacy. Design, setting, participants,
Autor:
Etienne Crickx, Selda Aydin, Alexandre Karras, Farah Tamirou, Jean-Claude Weill, Aurélie Hummel, Ailsa Robbins, Claude-Agnès Reynaud, Tatiana Fadeev, Frédéric Houssiau, Bernard Lauwerys, Tessa Huscenot, Nathalie Costedoat-Chalumeau, Matthieu Mahévas, Marion Rabant, Philippe Remy, Véronique Le Guern
Publikováno v:
Arthritis & rheumatology, Vol. 73, no. 8, p. 1461-1466 (2021)
OBJECTIVE: This study was undertaken to characterize kidney and urine antibody-secreting cells (ASCs) from patients with active lupus nephritis, before and after induction therapy. METHODS: We included patients with biopsy-proven active lupus nephrit
Creatinine Fluctuation in Patients With Lupus Nephritis: Considerations for Clinical Trial Endpoints
Autor:
Jorge Sanchez-Guerrero, Kenneth C. Kalunian, Brad H. Rovin, Salem Almaani, Eloisa Bonfa, Maria Dall'Era, Neil Solomons, Frédéric Houssiau, Udayan Bhatt, Cristina Arriens, Megan Mackay
Publikováno v:
Kidney international reports, vol 5, iss 8
Kidney International Reports
Kidney International Reports
Author(s): Almaani, Salem; Bhatt, Udayan; Arriens, Cristina; Bonfa, Eloisa; Dall'Era, Maria; Houssiau, Frederic; Kalunian, Kenneth; Mackay, Megan; Sanchez-Guerrero, Jorge; Solomons, Neil; Rovin, Brad H
Autor:
Ioannis Parodis, Farah Tamirou, Julia Weinmann-Menke, Alvaro Gomez, Selda Aydin, Christina Adamichou, Frédéric Houssiau, Nathalie Demoulin
Publikováno v:
Rheumatology, Vol. 59, no. 11, p. 3424-3434 (2020)
Objectives In patients with LN, clinical and histological responses to treatment have been shown to be discordant. We investigated whether per-protocol repeat kidney biopsies are predictive of LN relapses and long-term renal function impairment. Meth
Autor:
Frédéric Houssiau, Ioannis Parodis
Publikováno v:
Annals of the rheumatic diseases, Vol. 81, no.1, p. 15-19 (2022)
The current treatment paradigm in lupus nephritis consists of an initial phase aimed at inducing remission and a subsequent remission maintenance phase. With this so-called sequential treatment approach, complete renal response is achieved in a disap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce1d0985473391372ec87d75df0224dd
https://hdl.handle.net/2078.1/258814
https://hdl.handle.net/2078.1/258814
Autor:
Sabrina Valeria Porta, Antoine Enfrein, Frédéric Houssiau, Mercedes García, Richard Furie, Brad H. Rovin, Graciela S. Alarcón, Bernardo A. Pons-Estel, Guillermo J. Pons-Estel
Lupus nephritis (LN) affects about a third of patients with systemic lupus erythematosus. Although the use of conventional therapy has significantly improved the prognosis of LN, the response to treatment remains suboptimal, with high rates of relaps
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8d0904e97318338bc4cc2bcd00559e4
https://hdl.handle.net/20.500.12866/12887
https://hdl.handle.net/20.500.12866/12887
Autor:
Yehuda Schoenfeld, Carlos Vasconcelos, Josef S Smolen, Blanca Rubio, Ricard Cervera, Nathalie Costedoat-Chalumeau, Y K Onno Teng, Søren Jacobsen, Hermine I. Brunner, Mandana Nikpour, Anne Voss, Cindy Coney, Rebecca Fischer, Sang Cheol Bae, M.W.P. Tsang-A-Sjoe, Angela Tincani, Frédéric Houssiau, Elena Zakharhova, Bernadette van Leeuw, Michelle Petri, Eric F Morand, Ian N. Bruce, Maarten Limper, Dimitrios T. Boumpas, Victoria P. Werth, Murat Inanc, Anka Askenase, Ann E. Clarke, Thomas Dörner, Cynthia Aranow, Bernardo A. Pons-Estel, Matthias Schneider, Marta Mosca, László Czirják, George Bertsias, Michael M. Ward, Hendrika Bootsma, Juanita Romero-Diaz, Marzena Olesińska, Guillermo J. Pons-Estel, Xavier Mariette, Andrea Doria, Ruth D E Fritsch-Stork, Graciela S. Alarcón, Eloisa Bonfa, David A. Isenberg, Manuel F. Ugarte-Gil, Annegret Kuhn, Martin Aringer, Laurent Arnaud, Sandra V. Navarra, David Jayne, Anisur Rahman, Raquel Faria, Caroline Gordon, Alexandre E. Voskuyl, Ronald F van Vollenhoven
Publikováno v:
van Vollenhoven, R F, Bertsias, G, Doria, A, Isenberg, D, Morand, E, Petri, M A, Pons-Estel, B A, Rahman, A, Ugarte-Gil, M F, Voskuyl, A, Arnaud, L, Bruce, I N, Cervera, R, Costedoat-Chalumeau, N, Gordon, C, Houssiau, F A, Mosca, M, Schneider, M, Ward, M M, Alarcon, G, Aringer, M, Askenase, A, Bae, S-C, Bootsma, H, Boumpas, D T, Brunner, H, Clarke, A E, Coney, C, Czirják, L S, Dörner, T, Faria, R, Fischer, R, Fritsch-Stork, R, Inanc, M, Jacobsen, S R, Jayne, D, Kuhn, A, van Leeuw, B, Limper, M, Mariette, X, Navarra, S, Nikpour, M, Olesinska, M H, Pons-Estel, G, Romero-Diaz, J, Rubio, B, Schoenfeld, Y, Bonfá, E, Smolen, J, Teng, Y K O, Tincani, A, Tsang-A-Sjoe, M, Vasconcelos, C, Voss, A, Werth, V P, Zakharhova, E & Aranow, C 2021, ' 2021 DORIS definition of remission in SLE : Final recommendations from an international task force ', Lupus Science and Medicine, vol. 8, no. 1, e000538 . https://doi.org/10.1136/lupus-2021-000538
Lupus Science & Medicine
van Vollenhoven, R F, Bertsias, G, Doria, A, Isenberg, D, Morand, E, Petri, M A, Pons-Estel, B A, Rahman, A, Ugarte-Gil, M F, Voskuyl, A, Arnaud, L, Bruce, I N, Cervera, R, Costedoat-Chalumeau, N, Gordon, C, Houssiau, F A, Mosca, M, Schneider, M, Ward, M M, Alarcon, G, Aringer, M, Askenase, A, Bae, S C, Bootsma, H, Boumpas, D T, Brunner, H, Clarke, A E, Coney, C, Czirják, L, Dörner, T, Faria, R, Fischer, R, Fritsch-Stork, R, Inanc, M, Jacobsen, S, Jayne, D, Kuhn, A, van Leeuw, B, Limper, M, Mariette, X, Navarra, S, Nikpour, M, Olesinska, M H, Pons-Estel, G, Romero-Diaz, J, Rubio, B, Schoenfeld, Y, Bonfá, E, Smolen, J, Teng, Y K O, Tincani, A, Tsang-A-Sjoe, M, Vasconcelos, C, Voss, A, Werth, V P, Zakharhova, E & Aranow, C 2021, ' 2021 DORIS definition of remission in SLE : Final recommendations from an international task force ', Lupus Science and Medicine, vol. 8, no. 1, e000538 . https://doi.org/10.1136/lupus-2021-000538
Lupus Science and Medicine, Vol 8, Iss 1 (2021)
Lupus science & medicine, Vol. 8, no.1, p. e000538 [1-8] (2021)
Lupus Science & Medicine
van Vollenhoven, R F, Bertsias, G, Doria, A, Isenberg, D, Morand, E, Petri, M A, Pons-Estel, B A, Rahman, A, Ugarte-Gil, M F, Voskuyl, A, Arnaud, L, Bruce, I N, Cervera, R, Costedoat-Chalumeau, N, Gordon, C, Houssiau, F A, Mosca, M, Schneider, M, Ward, M M, Alarcon, G, Aringer, M, Askenase, A, Bae, S C, Bootsma, H, Boumpas, D T, Brunner, H, Clarke, A E, Coney, C, Czirják, L, Dörner, T, Faria, R, Fischer, R, Fritsch-Stork, R, Inanc, M, Jacobsen, S, Jayne, D, Kuhn, A, van Leeuw, B, Limper, M, Mariette, X, Navarra, S, Nikpour, M, Olesinska, M H, Pons-Estel, G, Romero-Diaz, J, Rubio, B, Schoenfeld, Y, Bonfá, E, Smolen, J, Teng, Y K O, Tincani, A, Tsang-A-Sjoe, M, Vasconcelos, C, Voss, A, Werth, V P, Zakharhova, E & Aranow, C 2021, ' 2021 DORIS definition of remission in SLE : Final recommendations from an international task force ', Lupus Science and Medicine, vol. 8, no. 1, e000538 . https://doi.org/10.1136/lupus-2021-000538
Lupus Science and Medicine, Vol 8, Iss 1 (2021)
Lupus science & medicine, Vol. 8, no.1, p. e000538 [1-8] (2021)
ObjectiveTo achieve consensus on a definition of remission in SLE (DORIS).BackgroundRemission is the stated goal for both patient and caregiver, but consensus on a definition of remission has been lacking. Previously, an international task force cons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16d6e38da7f7f84d16031aa203a45c99
https://research.vumc.nl/en/publications/5b360f84-970e-4080-9bda-283c187aeed2
https://research.vumc.nl/en/publications/5b360f84-970e-4080-9bda-283c187aeed2
Autor:
Frédéric Houssiau, Caroline Bouzin, Bernard Lauwerys, Pierre Coulie, Gaëlle Tilman, Christine Galant, Farah Tamirou, Nisha Limaye, Selda Aydin
Publikováno v:
RMD Open, Vol 7, Iss 3 (2021)
RMD open, Vol. 7, no. 3, p. e001844 [1-5] (2021)
RMD open, Vol. 7, no. 3, p. e001844 [1-5] (2021)
ObjectivesBecause a significant fraction of patients with lupus nephritis (LN) develops renal impairment, there is a need to better understand the mechanisms underlying disease progression. Here, we assessed for cellular senescence in the LN kidney,